Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine

Journal of Neurochemistry

Volumn 105, Issue 5, 2008, Pages 1716-1725

  Mijatovic, Jelena ^a   Patrikainen, Outi ^a   Yavich, Leonid ^c   Airavaara, Mikko ^a   Ahtee, Liisa ^a   Saarma, Mart ^b   Petteri Piepponen, T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Brain dopamine; Dopamine transporter; Glial cell line derived neurotrophic factor; In vivo voltammetry; Microdialysis; Ret receptor; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METIROSINE; POTASSIUM; TETRABENAZINE; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; STRIATE CORTEX;

ANIMALS; CORPUS STRIATUM; DOPAMINE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; SYNAPTIC TRANSMISSION; UP-REGULATION;

MUS;

EID: 43549095211     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05265.x     Document Type: Article

References (38)

1. Airavaara M., Mijatovic J., Vihavainen T., Piepponen T. P., Saarma M. Ahtee L. (2006) In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Synapse 59, 321 329.
2. Beck K. D., Irwin I., Valverde J., Brennan T. J., Langston J. W. Hefti F. (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16, 665 673.
3. Carlsson A. Lindqvist M. (1973) In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. J Neural Transm. 34, 79 91.
4. Chen K., Holschneider D. P., Wu W., Rebrin I. Shih J. C. (2004) A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J. Biol. Chem. 279, 39645 39652.
5. Colzi A., D'Agostini F., Cesura A. M., Borroni E. Da Prada M. (1993) Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo. J. Pharmacol. Exp. Ther. 265, 103 111.
6. Durbec P., Marcos-Gutierrez C. V., Kilkenny C. et al. (1996) GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789 793.
7. Eells J. B. (2003) The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease. Curr. Med. Chem. 10, 857 870.
8. Eng C. (1999) RET proto-oncogene in the development of human cancer. J. Clin. Oncol. 17, 380 393.
9. Franklin K. Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press INC, San Diego.
10. Fumagalli F., Gainetdinov R. R., Wang Y. M., Valenzano K. J., Miller G. W. Caron M. G. (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J. Neurosci. 19, 2424 2431.
11. Gash D. M., Zhang Z., Ovadia A. et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252 255.
12. Gonon F. G. (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neurosci. 24, 19 28.
13. Grace A. A., Floresco S. B., Goto Y. Lodge D. J. (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviours. Trends Neurosci. 30, 220 227.
14. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L. F. Gerhardt G. A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107 111.
15. Hudson J., Granholm A. C., Gerhardt G. A. et al. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425 432.
16. Huotari M., Gogos J. A., Karayiorgou M., Koponen O., Forsberg M., Raasmaja A., Hyttinen J. Mannisto P. T. (2002) Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur. J. Neurosci. 15, 246 256.
17. Kawagoe K. T., Garris P. A., Wiedemann D. J. Wightmann R. M. (1992) Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neurosci. 51, 55 64.
18. Lin L. F., Doherty D. H., Lile J. D., Bektesh S. Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130 1132.
19. Mijatovic J., Airavaara M., Planken A., Auvinen P., Raasmaja A., Piepponen T. P., Costantini F., Ahtee L. Saarma M. (2007) Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra. J. Neurosci. 27, 4799 4809.
20. Moore K. E. Dominic J. A. (1971) Tyrosine hydroxylase inhibitors. Fed. Proc. 30, 859 870.
21. Paxinos G. Franklin K. (2000) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego.
22. Popova N. K., Gilinskii M. A. Amstislavskaya T. G. (2004) Effect of monoamine oxidase gene knockout on dopamine metabolism in mouse brain structures. Bull. Exp. Biol. Med. 137, 382 384.
23. Pothos E. N. (2002) Regulation of dopamine quantal size in midbrain and hippocampal neurons. Behav. Brain Res. 130, 203 207.
24. Pothos E. N., Davila V. Sulzer D. (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci. 18, 4106 4118.
25. Rizzoli S. O. Betz W. J. (2005) Synaptic vesicle pools. Nat. Rev. Neurosci. 6, 57 69.
26. Roffler-Tarlov S., Sharman D. F. Tegerdine P. (1971) 3,4- dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine? Br. J. Pharmacol. 42, 343 351.
27. Rosenblad C., Kirik D. Bjorklund A. (2000) Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp. Neurol. 161, 503 516.
28. Salvatore M. F., Zhang J. L., Large D. M. et al. (2004) Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J. Neurochem. 90, 245 254.
29. Smith-Hicks C. L., Sizer K. C., Powers J. F., Tischler A. S. Costantini F. (2000) C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J. 19, 612 622.
30. Takahashi M. (2001) The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 12, 361 373.
31. Takahashi M. Cooper G. M. (1987) ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol. Cell. Biol. 7, 1378 1385.
32. Tomac A., Lindqvist E., Lin L. F., Ogren S. O., Young D., Hoffer B. J. Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335 339.
33. Treanor J. J., Goodman L., de Sauvage F. et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80 83.
34. Trupp M., Arenas E., Fainzilber M., Nilsson A. S., Sieber B. A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V. Arumae U. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785 789.
35. Wightman R. M., Amatore C., Engstrom R. C., Hale P. D., Kristensen E. W., Kuhr W. G. May L. J. (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neurosci. 25, 513 523.
36. Wightman R. M. Robinson D. L. (2002) Transient changes in mesolimbic dopamine and their association with 'reward'. J. Neurochem. 82, 721 735.
37. Wood P. L. Altar C. A. (1988) Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacol. Rev. 40, 163 187.
38. Yavich L. (1996) Two simultaneously working storage pools of dopamine in mouse caudate and nucleus accumbens. Br. J. Pharmacol. 119, 869 876.